A Brighter Decade Ahead for Biotech - Equity Research on Discovery Laboratories and Mylan Inc.
May 13 2011 - 9:00AM
Marketwired
Today, www.WorldStreetFundamentals.com released its industry report
highlighting Discovery Laboratories, Inc. (NASDAQ: DSCO) and Mylan
Inc. (NASDAQ: MYL). Full fundamental and technical analysis is
available at www.WorldStreetFundamentals.com/Reports.php.
Biotech is enabling creation of new drugs at a faster pace than
the traditional pharmaceutical model and some believe that after a
decade of mediocre performance it is approaching an inflection
point. Companies are much more conducive to focusing on
productivity and the sector is showing signs of being back to top
growth by 2013 due to the opportunity emerging markets have
created.
World Street Fundamentals has highlighted Discovery Laboratories
for its focus on developing surfactant therapies to treat
respiratory disorders and diseases. The Company's KL4 technology
produces a synthetic, peptide-containing surfactant (KL4
surfactant) that is structurally similar to pulmonary surfactant, a
substance produced naturally in the lung and essential for survival
and normal respiratory function.
In addition, its capillary aerosol-generating technology
(capillary aerosolization technology) produces a dense aerosol with
a defined particle size, to deliver its aerosolized KL4 surfactant
to the lung. The Company is developing its products, Surfaxin
(lucinactant), Surfaxin LS and Aerosurf, to address the respiratory
conditions affecting pediatric populations. The entire report on
Discovery Laboratories, Inc. (NASDAQ: DSCO) is available here:
www.WorldStreetFundamentals.com/ViewFullReport.245.php.
World Street has highlighted Mylan for its wide customer base in
more than 150 countries and territories. The Company operates in
two segments: Generics and Specialty. Mylan is a fully-integrated
global pharmaceutical company that develops, licenses,
manufactures, markets and distributes generic and branded generic
pharmaceuticals, specialty pharmaceuticals and active
pharmaceutical ingredients (API). The entire report on Mylan Inc.
(NASDAQ: MYL) is available here:
www.WorldStreetFundamentals.com/ViewFullReport.138.php.
About World Street World Street Fundamentals is an online portal
for professionals, investors and new-comers to the markets to find
in depth comprehensive research and research tools to help guide
you through the ever changing financial markets. Covering the top
performers in the hottest sectors and providing clarity to
investors around the world.
Contact: Adam Redford Email Contact
www.WorldStreetFundamentals.com
Discovery labs (NASDAQ:DSCO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Discovery labs (NASDAQ:DSCO)
Historical Stock Chart
From Sep 2023 to Sep 2024